H.C. Wainwright Has Just Reaffirmed $6.5000 Target Price Per Share on EDAP TMS (NASDAQ:EDAP) stock, While They’ve Also Reiterated Their “Buy” Rating

May 16, 2018 - By Vivian Park


EDAP TMS (NASDAQ:EDAP) Rating Reaffirmed

EDAP TMS (NASDAQ:EDAP) just had their share rating of a ‘”Buy”‘ issued by research analysts at H.C. Wainwright, who now has a $6.5000 TP on the $72.21 million market cap company or a 161.04 % upside potential. This key information was revealed in a note on Wednesday, 16 May.

The stock increased 2.47% or $0.06 during the last trading session, reaching $2.49. About 34,545 shares traded. EDAP TMS S.A. (NASDAQ:EDAP) has declined 8.41% since May 17, 2017 and is downtrending. It has underperformed by 19.96% the S&P500.

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company has market cap of $72.21 million. The firm operates in two divisions: High Intensity Focused Ultrasound , and Urology Devices and Services (UDS). It currently has negative earnings. The HIFU division develops, makes, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology.

More recent EDAP TMS S.A. (NASDAQ:EDAP) news were published by: Seekingalpha.com which released: “EDAP’s (EDAP) CEO Marc Oczachowski on Q1 2018 Results – Earnings Call Transcript” on May 15, 2018. Also Nasdaq.com published the news titled: “EDAP TMS SA : EDAP TMS SA to Announce First Quarter 2018 Financial Results on Monday, May 14” on May 02, 2018. Nasdaq.com‘s news article titled: “EDAP TMS SA : EDAP Reports 2018 First Quarter Results” with publication date: May 14, 2018 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.